Indian pharma’s strong fundamentals signal shift towards higher-margin, science-driven models: Bhavin Mehta: Nandita Vijayasimha, Bengaluru Monday, November 10, 2025, 08:00 Hrs ...
Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded an inspection with two observations at ...
SUMMARY – Performance review for the Six Months ended 30th September 2025 Overview Recording yet another strong quarterly ...
Bandhan Mutual Fund announces the launch of the Bandhan Healthcare Fund, an open-ended equity scheme investing across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback